BENSULFOID
LOE Approachingsulfur
NDATOPICALPOWDER
Approved
Sep 1940
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
2/8 — Basic
Drug data last refreshed 3d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BENSULFOID is a topical sulfur powder approved in 1940 for dermatological and systemic indications ranging from heart disease to various cancers. The mechanism of action and pharmacologic class are not well-characterized in available data. The indication portfolio is broad and clinically heterogeneous, spanning cardiovascular, neurological, gastrointestinal, renal, and oncologic conditions.
LOE Approaching
As an 83-year-old product approaching loss of exclusivity with minimal current commercial metrics, BENSULFOID likely operates a small, specialized team focused on maintaining legacy market share rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (3)
Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of Scabies
Started Mar 2022
60 enrolled
Scabies
Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH
Started Dec 2017
6 enrolled
Nonalcoholic SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Investigations Into ISCU Myopathy or Iron Sulfur Scaffold U Protein Myopathy
Started Feb 2012
2 enrolled
Myopathy
Career Relevance
BENSULFOID offers limited career growth potential due to its mature, post-LOE status and minimal linked job openings. Roles available are primarily focused on market maintenance, compliance, and operational continuity rather than strategic expansion or innovation.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.